1.
Automated Direct Selective Laser Trabeculoplasty: First Prospective Clinical Trial.
Goldenfeld Mordechai, Belkin Michael, Dobkin-Bekman Masha, Sacks Zachary, Blum Meirovitch Sharon, Geffen Noa et al.
Transl Vis Sci TechnolMar 202111 citationsClinical Trial
Automated Direct Selective Laser Trabeculoplasty (DSLT) safely and effectively reduced intraocular pressure and medication use in glaucoma patients, offering a promising noncontact treatment option.